Predicting Progression in BE: Recent Advances

February 11, 2021

Cernostics
Moderator Dr. Sri Komanduri is joined by Drs. Prasad Iyer and David Diehl to examine recent advances in Barrett’s esophagus and esophageal adenocarcinoma. Hear a panel discussion on the clinical challenges associated with predicting progression to esophageal adenocarcinoma in patients with Barrett’s esophagus. Learn about the role of TissueCypher® as an impactful tool in BE surveillance.
Cernostics, VirtualEd, replay, Sri Komanduri, Dr. Komanduri, Dr Komanduri, Dr. Sri Komanduri, Dr Sri Komanduri, Prasad Iyer, Dr. Iyer, Dr Iyer, Dr. Prasad Iyer, Dr Prasad Iyer, David Diehl, Dr. Diehl, Dr Diehl, Dr. David Diehl, Dr David Diehl, TissueCypher, BE, barrett’s esophagus, barretts esophagus, EAC, esophageal cancer, esophageal adenocarcinoma, BE progression, dysplasia, BE dysplasia, HGD, LGD, IM, HGD progression, BE surveillance, barrett’s esophagus surveillance, limitations of BE surveillance, EUS, EMR, EET, RFA, BE molecular markers, BE biomarkers, TissueCypher studies, NDBE